Profile: Akers Biosciences Inc (AKR.L)
AKR.L on London Stock Exchange
13.75GBp
3:00am EST
13.75GBp
3:00am EST
Price Change (% chg)
0.00p (+0.00%)
0.00p (+0.00%)
Prev Close
13.75p
13.75p
Open
13.75p
13.75p
Day's High
13.75p
13.75p
Day's Low
13.75p
13.75p
Volume
0
0
Avg. Vol
290,893
290,893
52-wk High
28.50p
28.50p
52-wk Low
8.50p
8.50p
Akers Biosciences, Inc. (ABI) is focused on the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate timesensitive therapeutic decisions. The Company’s main product is a disposable breathalyzer test that measures the blood alcohol content of the user.
Company Address
Akers Biosciences Inc
201 Grove Road
Thorofare NJ 08086
P: +1856.8488698
F: +1856.8480269
Company Web Links
| Name | Compensation |
|---|---|
| Mulhare, Edward | -- |
| Nicolette, Thomas | 218,747 |
| Akers, Raymond | 307,800 |
| Paratore, Robert | -- |
| Meyers, Leroy | -- |
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
